Sartorius Stedim Biotech recently announced the launch of its Integrated Solutions website (www.sartorius.com/en/integrated-solutions), an online resource and information centre to support its clients as they develop and implement entire single-use or hybrid biomanufacturing processes.
The new website is designed to assist clients in the implementation of flexible, scalable and cost-efficient bioprocesses by utilizing the tools, technologies, support and expertise available from Sartorius Stedim Biotech. To allow clients to better understand the effectiveness with which Integrated Solutions can be applied to their bioprocesses a comprehensive portfolio of case studies is available from companies such as Boehringer Ingelheim, Wuxi AppTec, Mabion, DMBio and Bayer.
The biopharmaceutical industry is being forced to adapt to changing and challenging market conditions. Reducing costs and increasing process optimization are becoming increasingly important due to pressures from healthcare providers and competition from biosimilars. Sartorius Stedim Biotech’s new website describes how the company addresses these challenges through partnering with clients to design and develop entire single-use and hybrid processes for the manufacture of biopharmaceuticals.
Ensuring clients benefit from the shortest time to market, Sartorius is using the Integrated Solutions website to showcase its new ‘mAb Process Platform’. The new platform is a result of the company’s innovative ‘Process4Success®’ initiative which seeks to leverage both novel single-use processing technologies and the expertise within the organization to define sequences of unit operations that can be combined to create an entire bioprocess line.
